Federal regulators in the United States are pushing harder than ever to reduce and eventually replace animal testing in drug ...

The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t ...

Health authorities in the U.S. are continuing their move away from animal testing in drug development, with the FDA signaling ...

Non-animal testing methods could save drugmakers time and money, officials say ...

Stem Pharm, a Madison biotech startup, is using lab-created 3D "organoids" to develop a treatment for Alzheimer's disease. In April, the FDA and NIH announced plans to incentivize so-called "new ...

The guidance clarifies what sponsors should consider when putting together an application for the validation of a NAM ...

The FDA has released draft guidance aimed at helping drug developers shift away from traditional animal testing as the ...

The U.S. Food and Drug Administration (FDA) recently announced it plans to phase out animal testing in the development of monoclonal antibody therapies and other drugs and biological products “with ...

The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new ...

(MENAFN- EIN Presswire) EINPresswire/ -- The shift towards ethical and innovative testing methods is reshaping the landscape of product safety evaluation. As industries move away from traditional ...

There’s one area of surprising agreement in the often adversarial relationship between conservatives and the scientific community: the need to phase out animal testing in biomedical research. The new ...

The U.S. Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that there ...